» Articles » PMID: 24099319

Investigating Citrullinated Proteins in Tumour Cell Lines

Overview
Publisher Biomed Central
Date 2013 Oct 9
PMID 24099319
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The conversion of arginine into citrulline, termed citrullination, has important consequences for the structure and function of proteins. Studies have found PADI4, an enzyme performing citrullination, to be highly expressed in a variety of malignant tumours and have shown that PADI4 participates in the process of tumorigenesis. However, as citrullinated proteins have not been systematically investigated in tumours, the present study aimed to identify novel citrullinated proteins in tumours by 2-D western blotting (2-D WB).

Methods: Two identical two-dimensional electrophoresis (2-DE) gels were prepared using extracts from ECA, H292, HeLa, HEPG2, Lovo, MCF-7, PANC-1, SGC, and SKOV3 tumour cell lines. The expression profiles on a 2-DE gel were trans-blotted to PVDF membranes, and the blots were then probed with an anti-citrulline antibody. By comparing the 2-DE profile with the parallel 2-D WB profile at a global level, protein spots with immuno-signals were collected from the second 2-DE gel and identified using mass spectrometry. Immunoprecipitation was used to verify the expression and citrullination of the targeted proteins in tumour cell lines.

Results: 2-D WB and mass spectrometry identified citrullinated α-enolase (ENO1), heat shock protein 60 (HSP60), keratin 8 (KRT8), tubulin beta (TUBB), T cell receptor chain and vimentin in these cell lines. Immunoprecipitation analyses verified the expression and citrullination of ENO1, HSP60, KRT8, and TUBB in the total protein lysates of the tumour cell lines.

Conclusions: The citrullination of these proteins suggests a new mechanism in the tumorigenic process.

Citing Articles

Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.

Shi Y, Wu Z, Liu S, Zuo D, Niu Y, Qiu Y Nat Commun. 2024; 15(1):7930.

PMID: 39256398 PMC: 11387718. DOI: 10.1038/s41467-024-52170-3.


GnRH Induces Citrullination of the Cytoskeleton in Murine Gonadotrope Cells.

Quigley E, DeVore S, Khan S, Geisterfer Z, Rothfuss H, Sequoia A Int J Mol Sci. 2024; 25(6).

PMID: 38542155 PMC: 10970285. DOI: 10.3390/ijms25063181.


Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease.

Nava-Quiroz K, Lopez-Flores L, Perez-Rubio G, Rojas-Serrano J, Falfan-Valencia R Cells. 2023; 12(24).

PMID: 38132149 PMC: 10741699. DOI: 10.3390/cells12242829.


Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance.

Tabatabaee A, Nafari B, Farhang A, Hariri A, Khosravi A, Zarrabi A Cancer Metastasis Rev. 2023; 43(1):363-377.

PMID: 38012357 DOI: 10.1007/s10555-023-10154-7.


Citrullination Post-Translational Modification: State of the Art of Brain Tumor Investigations and Future Perspectives.

Rossetti D, Muntiu A, Massimi L, Tamburrini G, Desiderio C Diagnostics (Basel). 2023; 13(18).

PMID: 37761239 PMC: 10529966. DOI: 10.3390/diagnostics13182872.


References
1.
Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K . The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2004; 44(3):293-8. DOI: 10.1093/rheumatology/keh473. View

2.
Cherrington B, Zhang X, McElwee J, Morency E, Anguish L, Coonrod S . Potential role for PAD2 in gene regulation in breast cancer cells. PLoS One. 2012; 7(7):e41242. PMC: 3404060. DOI: 10.1371/journal.pone.0041242. View

3.
Baka Z, Barta P, Losonczy G, Krenacs T, Papay J, Szarka E . Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production. Int Immunol. 2011; 23(6):405-14. DOI: 10.1093/intimm/dxr026. View

4.
Li P, Wang D, Yao H, Doret P, Hao G, Shen Q . Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene. 2010; 29(21):3153-62. PMC: 2913128. DOI: 10.1038/onc.2010.51. View

5.
Castilla C, Congregado B, Conde J, Medina R, Torrubia F, Japon M . Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology. 2010; 76(4):1017.e1-6. DOI: 10.1016/j.urology.2010.05.045. View